0001628280-24-001036.txt : 20240110 0001628280-24-001036.hdr.sgml : 20240110 20240110161515 ACCESSION NUMBER: 0001628280-24-001036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240108 FILED AS OF DATE: 20240110 DATE AS OF CHANGE: 20240110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lewis William CENTRAL INDEX KEY: 0001402051 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30739 FILM NUMBER: 24526745 MAIL ADDRESS: STREET 1: 10 FINDERNE AVENUE STREET 2: BUILDING 10 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSMED Inc CENTRAL INDEX KEY: 0001104506 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 541972729 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-977-9900 MAIL ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: INSMED INC DATE OF NAME CHANGE: 20000128 4 1 wk-form4_1704921303.xml FORM 4 X0508 4 2024-01-08 0 0001104506 INSMED Inc INSM 0001402051 Lewis William 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 1 1 0 0 Chair and CEO 1 Common Stock 2024-01-08 4 M 0 24951 20.49 A 398489 D Common Stock 2024-01-08 4 S 0 24951 29.11 D 373538 D Common Stock 2024-01-08 4 M 0 20169 20.49 A 393707 D Common Stock 2024-01-08 4 S 0 20169 29.88 D 373538 D Common Stock 2024-01-09 4 S 0 9887 28.72 D 363651 D Common Stock 233924 I By ARTICLE 4 KATIE PROCTER DYNASTY TRUST Common Stock 500 I By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020 Stock Option (right to buy) 20.49 2024-01-08 4 M 0 45120 20.49 A 2024-01-10 Common Stock 45120 0 D This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. This is the weighted average sales price representing 24,951 shares sold at prices ranging from $28.71 to $29.68 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. This is the weighted average sales price representing 20,169 shares sold at prices ranging from $29.88 to $29.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees. This is the weighted average sales price representing 9,887 shares sold at prices ranging from $28.62 to $28.84 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. All options are currently exercisable and were scheduled to expire on January 10, 2024. /s/ William Lewis, by Michael A. Smith as Attorney in Fact 2024-01-10